CTSH vs TPST · P/E 12, rev $21.11B vs $26.3M cap
Cognizant Technology Solutions Corp Class A (CTSH) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported CTSH revenue for 2025-12-31 was $21.11B. Net income was $2.23B. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
TPST does not have a complete income-statement cache yet.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. TPST currently screens at market cap $26.3M.
Not investment advice. Open the CTSH and TPST stock pages for the full models.
Not investment advice.